13F-HR filed by Parkman Healthcare Partners LLC
Parkman Healthcare Partners LLC filed this 13F-HR for the quarter ended 2026-06-30, filed 2026-08-14, with 77 holding rows worth $976,827,960.
- Accession
- 0001420506-26-001734
- Filer
- CIK 1777015
- Filed
- 2026-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2026
A holdings report, 77 entries on the cover page, a total value of $976,827,960 stated on the cover page (in dollars after the unit check, H1), rows summing to $976,827,960 with VALUE read as dollars as filed, 13F file number 028-19992. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| MBX BIOSCIENCES INC COM | 55287L101 | Stock | 800,173 | $44,169,550 | dollars as filed | |
| Eli Lilly and Company | 532457108 | COM | 35,000 | $41,980,050 | dollars as filed | |
| CVS Health Corporation | 126650100 | COM | 391,791 | $40,530,779 | dollars as filed | |
| DEXCOM INC COM | 252131107 | Stock | 534,767 | $36,016,557 | dollars as filed | |
| PTC THERAPEUTICS INC | 69366J200 | COM | 435,691 | $35,539,315 | dollars as filed | |
| ARCUS BIOSCIENCES INC | 03969F109 | COM | 919,266 | $28,340,971 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 485,661 | $26,065,426 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 1,377,576 | $25,306,071 | dollars as filed | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 669,046 | $24,828,297 | dollars as filed | |
| INHIBRX BIOSCIENCES INC | 45720N103 | COM | 256,950 | $24,346,013 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 397,379 | $23,985,796 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 577,036 | $23,444,973 | dollars as filed | |
| UnitedHealth Group Inc | 91324P102 | COM | 55,921 | $23,242,445 | dollars as filed | |
| Stryker Corporation | 863667101 | COM | 67,973 | $21,400,619 | dollars as filed | |
| IQVIA HLDGS INC COM | 46266C105 | Stock | 105,811 | $20,444,801 | dollars as filed | |
| ZIMMER BIOMET HOLDINGS INC COM | 98956P102 | Stock | 232,557 | $20,020,832 | dollars as filed | |
| INSULET CORP COM | 45784P101 | Stock | 131,378 | $20,002,301 | dollars as filed | |
| ASSEMBLY BIOSCIENCES INC | 045396207 | COMMON STOCK | 721,181 | $19,818,054 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 877,256 | $19,176,816 | dollars as filed | |
| EYEPOINT INC COM NEW | 30233G209 | Stock | 1,288,163 | $18,420,731 | dollars as filed | |
| TENET HEALTHCARE CORP COM NEW | 88033G407 | Stock | 97,280 | $18,199,142 | dollars as filed | |
| LIVANOVA PLC | G5509L101 | SHS | 210,529 | $17,311,800 | dollars as filed | |
| ANI PHARMACEUTICALS INC | 00182C103 | COM | 202,907 | $16,796,641 | dollars as filed | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 1,624,279 | $16,242,790 | dollars as filed | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 50,672 | $15,253,792 | dollars as filed | |
| INDIVIOR PHARMACEUTICALS INC | 45579U109 | COM | 364,269 | $14,945,957 | dollars as filed | |
| ENVISTA HOLDINGS CORPORATION | 29415F104 | COM | 553,916 | $14,595,687 | dollars as filed | |
| BRIGHT MINDS BIOSCIENCES INC | 10919W405 | COMMON STOCK | 205,053 | $14,394,721 | dollars as filed | |
| XERIS BIOPHARMA HOLDINGS INC | 98422E103 | COM | 1,807,621 | $14,316,358 | dollars as filed | |
| AVALO THERAPEUTICS INC | 05338F306 | COMMON STOCK | 766,290 | $14,161,039 | dollars as filed | |
| 4D MOLECULAR THERAPEUTICS INC COM | 35104E100 | Stock | 948,184 | $12,610,847 | dollars as filed | |
| IMMUNOME INC | 45257U108 | COM | 594,202 | $12,591,140 | dollars as filed | |
| STOKE THERAPEUTICS INC | 86150R107 | COM | 355,443 | $11,630,095 | dollars as filed | |
| WATERS CORP COM | 941848103 | Stock | 30,206 | $11,328,458 | dollars as filed | |
| ALTO NEUROSCIENCE INC COM SHS | 02157Q109 | Stock | 429,035 | $11,322,234 | dollars as filed | |
| ORUKA THERAPEUTICS INC COM | 687604108 | Stock | 113,188 | $10,772,102 | dollars as filed | |
| ADAPTIVE BIOTECHNOLOGIES CORP COM | 00650F109 | Stock | 486,984 | $10,445,807 | dollars as filed | |
| ABSCI CORPORATION | 00091E109 | COM | 894,374 | $10,365,795 | dollars as filed | |
| MINERALYS THERAPEUTICS INC | 603170101 | COM | 380,354 | $10,261,951 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 253,365 | $9,805,226 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 208,170 | $9,588,310 | dollars as filed | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 150,000 | $9,441,000 | dollars as filed | |
| AMNEAL PHARMACEUTICALS INC | 03168L105 | COM STK CL A | 541,190 | $9,367,999 | dollars as filed | |
| IRHYTHM HOLDINGS INC COM | 450056106 | Stock | 67,267 | $8,001,410 | dollars as filed | |
| CRYOPORT INC COM PAR $0.001 | 229050307 | Stock | 508,324 | $7,980,687 | dollars as filed | |
| Boston Scientific Corporation | 101137107 | COM | 180,481 | $7,702,929 | dollars as filed | |
| CLIMB BIO INC | 28658R106 | COMMON STOCK | 563,484 | $7,347,831 | dollars as filed | |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 398,782 | $7,162,125 | dollars as filed | |
| UPSTREAM BIO INC | 91678A107 | COMMON STOCK | 935,247 | $6,471,909 | dollars as filed | |
| RESMED INC COM | 761152107 | Stock | 32,983 | $6,427,727 | dollars as filed | |
| UROGEN PHARMA LTD | M96088105 | COMMON STOCK | 174,064 | $6,405,555 | dollars as filed | |
| ALIGN TECHNOLOGY INC COM | 016255101 | Stock | 36,963 | $6,234,180 | dollars as filed | |
| CARLSMED INC | 14280C105 | COMMON STOCK | 597,318 | $6,200,161 | dollars as filed | |
| AVEANNA HEALTHCARE HLDGS INC | 05356F105 | COM | 714,451 | $6,122,845 | dollars as filed | |
| CAREDX INC | 14167L103 | COM | 202,417 | $5,768,885 | dollars as filed | |
| SI BONE INC | 825704109 | COM | 328,686 | $5,364,156 | dollars as filed | |
| VIR BIOTECHNOLOGY INC | 92764N102 | COM | 475,279 | $4,843,093 | dollars as filed | |
| ERASCA INC COM | 29479A108 | Stock | 258,684 | $4,739,091 | dollars as filed | |
| SHOULDER INNOVATIONS INC | 82537J108 | COMMON STOCK | 226,212 | $4,587,579 | dollars as filed | |
| WAYSTAR HLDG CORP | 946784105 | COM | 203,986 | $4,187,833 | dollars as filed | |
| ALPHATEC HLDGS INC | 02081G201 | COM NEW | 449,943 | $3,892,007 | dollars as filed | |
| ANNEXON INC | 03589W102 | COM | 641,029 | $3,660,276 | dollars as filed | |
| CASTLE BIOSCIENCES INC | 14843C105 | COMMON STOCK | 144,791 | $3,453,265 | dollars as filed | |
| MINIMED GROUP INC | 60365F109 | COMMON STOCK | 226,446 | $3,385,368 | dollars as filed | |
| EIKON THERAPEUTICS INC | 282564103 | COMMON STOCK | 256,053 | $3,341,492 | dollars as filed | |
| VIATRIS INC COM | 92556V106 | Stock | 200,000 | $3,176,000 | dollars as filed | |
| GRAIL INC | 384747951 | PUT | 46,000 | $3,140,420 | dollars as filed | put |
| ARTIVION INC | 228903100 | COM | 138,940 | $3,121,982 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 10,000 | $2,447,700 | dollars as filed | |
| OPTIMIZERX CORP | 68401U204 | COM NEW | 350,347 | $2,003,985 | dollars as filed | |
| INSPIREMD INC | 45779A846 | COM | 2,416,518 | $1,691,804 | dollars as filed | |
| HEMAB THERAPEUTICS HLDGS INC | 423494103 | COM SHS | 45,000 | $1,652,850 | dollars as filed | |
| PULMONX CORP | 745848101 | COM | 646,564 | $840,533 | dollars as filed | |
| ARS PHARMACEUTICALS INC | 82835W108 | COM | 102,700 | $822,627 | dollars as filed | |
| EDAP TMS S A | 268311107 | SPONSORED ADR | 154,832 | $802,030 | dollars as filed | |
| OVID THERAPEUTICS INC | 690469101 | COMMON STOCK | 197,947 | $532,477 | dollars as filed | |
| ENTERA BIO LTD | M40527109 | SHS | 274,497 | $485,860 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-26-001734 | this filing | 2026-08-14 | acceptance time not in the bulk data set |